Letrozole
NDC 59651-180, Letrozole, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 59651-180
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211717
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LETROZOLE2.5 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-180-30 | 59651018030 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-180-30) |
| 59651-180-90 | 59651018090 | 90 TABLET, FILM COATED in 1 BOTTLE (59651-180-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ff7325d2-3383-4ff9-a187-9350e3538640NADAC price for package 59651018030
GET /v1/drugs/nadac/59651018030
Use it
Look up 59651-180 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.